Dynavax Technologies Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
January 12 2018 - 4:01PM
Dynavax Technologies Corporation (NASDAQ:DVAX) today announced that
on January 10, 2018 the Compensation Committee of Dynavax’s Board
of Directors approved the grant of inducement stock options to
purchase an aggregate of 57,000 shares of common stock to six new
employees. These awards were granted pursuant to the Dynavax
Technologies Corporation Inducement Plan, as an inducement material
to the new employees entering into employment with Dynavax, in
accordance with the NASDAQ Listing Rule 5635(c)(4).
Dynavax granted stock options to purchase shares of Dynavax’s
common stock to the new employees with an exercise price of $16.85
per share, the closing price of Dynavax’s common stock on January
10, 2018, the effective date of such grants. The stock options
awarded vest over a three-year period, with one-third of the shares
subject to such awards vesting on the first anniversary of the
award’s vesting commencement date, and 1/36th of the shares subject
to such awards vesting monthly thereafter, subject to each such
employee’s continued employment with Dynavax on such vesting
dates.
Dynavax is providing this information in accordance with NASDAQ
Listing Rule 5635(c)(4).
About DynavaxDynavax is a
commercial-stage biopharmaceutical company focused on leveraging
the power of the body's innate and adaptive immune responses
through toll-like receptor (TLR) stimulation. Dynavax discovers and
develops novel vaccines and immuno-oncology therapeutics. The
Company’s first commercial product, HEPLISAV-B™ [Hepatitis B
Vaccine (Recombinant), Adjuvanted], is approved in the United
States. Dynavax's lead immunotherapy product, SD-101, is an
investigational cancer immunotherapeutic currently being evaluated
in Phase 1/2 studies and its second cancer immunotherapeutic,
DV281, is in Phase 1 development. For more information, visit
www.dynavax.com.
Contact:
Ryan Spencer
VP, Corporate Strategy & Communications
510.665.4618
rspencer@dynavax.com
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024